| AD | Alzheimer’s disease |
| Akt | Protein kinase B |
| AP-1 | Activator protein 1 |
| Aβ | Amyloid beta peptide |
| BBB | Blood–brain barrier |
| C3G | Cyanidin-3-O-glucoside |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| DG | D-galactose |
| ERK | Extracellular signal-regulated kinase |
| GA | Gallic acid |
| HBA | 4-hydroxybenzoic acid |
| IFN | Interferon |
| IKK | IκB kinase |
| IL | Interleukin |
| iNOS | Nitric oxide synthase |
| JAK | Janus kinase |
| JNK | c-jun N-terminal kinase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MLK3 | Mixed-lineage protein kinase 3 |
| MS | Multiple sclerosis |
| mTOR | Mammalian target of rapamycin |
| NF-κB | Nuclear factor kappa B |
| NLRP3 | NLR family pyrin domain-containing protein 3 |
| NO | Nitric oxide |
| PA | Protocatechuic acid |
| PD | Parkinson’s disease |
| PGE2 | Prostaglandin E2 |
| PI3K | Phosphoinositide 3-kinase |
| PND | Perioperative neurocognitive disorder |
| ROS | Reactive oxygen species |
| STAT | Signal transducer and activator of transcription |
| TLR | Toll-like receptor |
| TNF | Tumor necrosis factor |
| VA | Vanillic acid |